EUVIMED · CrossrefJournal
Human Gene Therapy
ISSN 1043-0342 · SAGE Publications
Latest articles
Safety, Tolerability, and Efficacy of a Prophylactic Sirolimus Protocol for Patients Receiving Delandistrogene Moxeparvovec-Rokl Gene Therapy
Adeno-Associated Virus-Mediated Central Nervous System Gene Transfer to Suppress Alzheimer’s Disease High-Risk APOE4 Variant and Replace with Protective APOE2
Engineering Human Hematopoietic Stem and Progenitor Cells for Antigen Expression in Antigen-Presenting Cells
InsightRP2—An Interdisciplinary Approach Toward Therapy Development in RP2 -Associated Retinopathy
Development of an AAV-Encoded Adenine Base Editor for Duchenne Muscular Dystrophy
Automated Production of Gene-Edited CAR-T Cells for People Living with HIV
Beyond Viruses: Transposons and CRISPR-Programmable Nonviral Systems for Genome Engineering
Food and Drug Administration Grants Ultragenyx’s Fayuvi™ First-Ever Approval for Sanfilippo Syndrome Type A Treatment
The preCDD Network as a Model for Academic Preclinical Cancer Drug Development in Germany
An Investigation on the Association Between HIV-1 Integrase and Gene Knock-out
AAV6 Preferentially Transduces Human Choroid Plexus Epithelium in Cerebrospinal Fluid
Capsid Engineering of Adeno-Associated Viruses for Targeted Gene Therapy in Kidney Diseases
Novel VSV-G Variants with Enhanced Blinding for Targeted Delivery of Lentiviral Vectors
Harvest Process and Affinity Resin Selection Impacts on Adeno-Associated Virus Residual Host Cell Protein Retention
Prime Editing of Alzheimer’s Disease High-Risk APOE4 Allele by Brain-Directed Adeno-Associated Virus Vectors
FDA Issues Plausible Mechanism Pathway Draft Guidance
Efficient LAMA1 Gene Activation by Epigenome Editing as a Therapeutic Approach for LAMA2-CMD
Prenatal Intraportal Delivery of Polymeric Nanoparticles to Fetal Rhesus Monkeys ( Macaca mulatta )
Advancing Potency Assay Development for Advanced Therapy Medicinal Products: A Comprehensive Approach and Regulatory Insights
A Comprehensive Review of Clinically Applied Adeno-Associated Virus-Based Gene Therapies for Ocular Disease
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments
Advancements in Nonviral Gene Editing Strategies for Rare Diseases
Trojan Horse-Like Vehicles for CRISPR-Cas Delivery: Engineering Extracellular Vesicles and Virus-Like Particles for Precision Gene Editing in Cystic Fibrosis
ATOH-1 Gene Therapy in Acquired Sensorineural Hearing Loss: A Meta-Analysis and Bioinformatic Analysis of Preclinical Studies
Oncolytic Adenovirus Armoring with CXCL9 and IL15 Shows Potent Antitumor Activity and Boosts CAR-T Therapy for Prostate Cancer
Progress, Applications and Prospects of CRISPR-Based Genome Editing Technology in Gene Therapy for Cancer and Sickle Cell Disease
Overexpression of ABCA1 in Carotid Endothelium of Hyperlipidemic Rabbits Modulates Vascular Inflammation
Comprehensive Review of Osteogenesis Imperfecta: Current Treatments and Future Innovations
Interlaboratory Measurement of Adeno-Associated Virus: Comparative Quantification of Full and Empty Capsids
Prevalence of Neutralizing Antibodies Against AAV Serotypes 2 and 9 in Healthy Participants from Multiple Centers Across China and Patients with DMD/BMD
Volumes
2026 · 982025 · 982024 · 952023 · 1312022 · 1402021 · 1602020 · 1592019 · 1442018 · 1412017 · 1222016 · 1112015 · 962014 · 1382013 · 1142012 · 1472011 · 1852010 · 1592009 · 1822008 · 2222007 · 1222006 · 2492005 · 2422004 · 1452003 · 1702002 · 2022001 · 2002000 · 2261999 · 2991998 · 3081997 · 2251996 · 2211995 · 1681994 · 1701993 · 1071992 · 881991 · 571990 · 55
EUVIMED